|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 USD | 0.00% |
|
-16.67% | -83.81% |
| Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
| Mar. 12 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: July 1, 2019 4:30 P.M. | |
Form: | S-3 |
CIK: | 0000850261 |
Company Name: | Sorrento Therapeutics, Inc. |
File Number: | 333-232163 |
Attachments
Disclaimer
Sorrento Therapeutics Inc. published this content on 01 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 July 2019 10:07:01 UTC
| 1st Jan change | Capi. | |
|---|---|---|
| -83.81% | 10.87M | |
| -2.26% | 103B | |
| +1.41% | 95.71B | |
| +0.70% | 22.02B | |
| -17.84% | 20.9B | |
| -9.33% | 17.85B | |
| -42.83% | 16.21B | |
| -17.63% | 15.52B | |
| +4.55% | 13.86B | |
| +32.11% | 12.04B |
SORRENTO THERAPEUTICS, INC. 
